Vodafone Technology Is Bringing Clinical Trial Results In Real-Time

Vodafone and PHT Corporation, are working together to connect the PHT electronic clinical outcome assessment (eCOA) system to Vodafone’s global M2M network. Vodafone’s Machine-to-Machine (M2M) Technology Enables PHT Corporation to more efficiently manage worldwide clinical trials through real-time access to patient experience data. Learn more here. (Source: Vodafone, 3/24/15)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
Research Operations for Secondary Use of Clinical Sites’ EMR 11/21/2019